Kronos Bio Appoints Elena Ridloff, CFA, to Board of Directors

September 15, 2020

Kronos Bio Announces $155 Million Private Financing

August 24, 2020

Kronos Bio Appoints Dr. Yasir Al-Wakeel as Chief Financial Officer and Head of Corporate Development

August 19, 2020

Kronos Bio Appoints Barbara Kosacz, Chief Operating Officer and General Counsel

July 20, 2020

Kronos Bio and Gilead Sciences Enter Into Asset Purchase Agreement for Gilead’s SYK Inhibitor Portfolio

July 16, 2020

Kronos Bio Reports Positive Results of Preclinical Study of KB-0742, an Investigational CDK9 Inhibitor, Demonstrating Potency, Selectivity and Anti-tumor Activity in Prostate Cancer Model

July 9, 2020

Kronos Bio Appoints Industry Veteran, Jennifer Nicholson, M.H.A., as Vice President, Regulatory Affairs

July 7, 2020

Kronos Bio Expands Leadership Team with Appointment of Seasoned Drug Discovery Leader Christopher Dinsmore, Ph.D., as Chief Scientific Officer

June 16, 2020

Kronos Bio Announces Participation in the Jefferies Virtual Healthcare Conference

May 26, 2020

Kronos Bio Expands Clinical Team with the Appointment of Zung To as Vice President, Clinical Operations

May 19, 2020

Kronos Bio To Present At The 38th Annual J.P. Morgan Healthcare Conference

January 10, 2020

Kronos Bio Appoints Medicinal Chemist Wes Trotter, Ph.D. as Vice President, Chemistry

January 8, 2020

Kronos Bio Appoints Biopharma Industry Veteran Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer

November 20, 2019

Kronos Bio Strengthens Senior Management Team with New Leadership Appointments

October 24, 2019

Kronos Bio Expands Scientific Advisory Board with Addition of Roger D. Kornberg, Ph.D.

August 7, 2019

Kronos Bio Completes $105 Million Series A Financing

July 18, 2019

Kronos Bio Appoints Philip Gutry as Chief Business Officer to Expand Pipeline Opportunities

November 27, 2018

FierceBiotech names Kronos Bio as one of its “Fierce 15” Biotech Companies of 2018

October 3, 2018

Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing

May 22, 2018